Prestige Wealth Management Group LLC Ionis Pharmaceuticals Inc Transaction History

Prestige Wealth Management Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $2,012 - $2,433	-60 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$34.54 - $47.25 $1,450 - $1,984	-42 Reduced 41.18%	60 $2,000
Q1 2021 May 13, 2021	SELL	$42.51 - $63.78 $2,253 - $3,380	-53 Reduced 34.19%	102 $5,000
Q4 2020 Feb 17, 2021	BUY	$45.3 - $60.27 $4,303 - $5,725	95 Added 158.33%	155 $8,000
Q2 2020 Aug 13, 2020	SELL	$46.85 - $61.05 $21,176 - $27,594	-452 Reduced 88.28%	60 $4,000
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $122,096 - $186,079	-2,935 Reduced 85.15%	512 $24,000
Q4 2019 Jan 28, 2020	SELL	$53.85 - $65.27 $1,400 - $1,697	-26 Reduced 0.75%	3,447 $208,000
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $201,571 - $246,247	3,413 Added 5688.33%	3,473 $208,000
Q4 2018 Apr 16, 2019	BUY	$43.37 - $59.54 $2,602 - $3,572	60 New	60 $3,000

394

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.59B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Prestige Wealth Management Group LLC with notifications on news.